| 今开：1.1 | 昨收：1.09 |
| 最高：1.15 | 最低：1.05 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.26947652E8 |
Karyopharm(KPTI)03-05 08:45
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025190 Size: 7 KB 网页链接查看全文
Karyopharm(KPTI)03-05 08:45
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025188 Size: 7 KB 网页链接查看全文
Karyopharm(KPTI)03-01 06:45
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023281 Size: 4 KB 网页链接查看全文
Karyopharm(KPTI)03-07 05:15
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027153 Size: 5 KB 网页链接查看全文
疑夕2015-05-14 10:38
$Karyopharm Therapeutics(KPTI)$ Selinexor妇产科肿瘤数据不算好：DCR in evaluable pts: OC: 36%; EC: 64%; CC: 28%. ORR in evaluable pts: OC: 9%; EC: 18%; CC 7%.查看全文
疑夕2015-05-14 10:36
$Karyopharm Therapeutics(KPTI)$ Selinexor肉瘤数据不佳：Of the 33 evaluable patients, stable disease was seen in 21/33 (64%) of pts along with decrease of tumor burden (ranging from 5 – 23%) in 7 patients. There were 12 pts (36%) that progressed.查看全文
淡投2015-05-14 08:11
$Karyopharm Therapeutics(KPTI)$ 网页链接 A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis. "Based on promising results a la...查看全文
淡投2015-05-14 02:25
$Karyopharm Therapeutics(KPTI)$ plans to present solid tumor data on single agent selinexor at the upcoming 2015 American Society of Clinical Oncology (ASCO) annual meeting being held May 29 to June 2, 2015 in Chicago. Data to be presented include Phase 2 clinical updates in ...查看全文
疑夕2015-05-06 11:50
ASCO2015看点：$Karyopharm Therapeutics(KPTI)$ 将公布核转运蛋白XPO1抑制剂治疗胶质母细胞瘤的II期临床进展，这也是一个first-in-class，全世界只有他们一家在做这个靶点，去年4月份启动的II期临床。(ASCO2015的摘要将在5月13日收盘后公开，想参与赌博的同学记得及时下注，想规避风险的同学记得...查看全文
囧尼2014-09-28 14:25
9/29 watchlist：$Cross Country Healthcare(CCRN)$ $Federated National(FNHC)$ $Karyopharm Therapeutics(KPTI)$ $Merrimack(MACK)$ $Magellan Petroleum(MPET)$ $OVASCIENCE INC(OVAS)$ $Sonic(SONC)$ $CIVEO CORP(CVEO)$ $哈尼斯品牌服装(HBI)$查看全文
IB美国盈透证券2014-06-23 15:27
作者：IB股票借贷服务台
股票借贷更新：股票借贷服务台可找到的最活跃的股票
下方表格显示的是2014年6月9日至2014年6月13日期间盈透股票借贷服务台可找到的最活跃的15支股票。
加注：“仁心生物医疗”、“艾丹尼斯生物制药”为盈透翻译团队建议的翻译名称。
给众多美股提议译名，...查看全文
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046871 Size: 4 KB 网页链接
$Karyopharm(KPTI)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-101705 Act: 34 Size: 2 MB 网页链接
$Karyopharm(KPTI)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-045717 Act: 34 Size: 7 MB 网页链接
$Karyopharm(KPTI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-045718 Act: 34 Size: 1 MB 网页链接
$Karyopharm(KPTI)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001193125-24-089714 Act: 34 Size: 28 KB 网页链接
$Karyopharm(KPTI)$ PRE 14A Other preliminary proxy statements Accession Number: 0000950170-24-042645 Act: 34 Size: 6 MB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042350 Size: 4 KB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027153 Size: 5 KB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025188 Size: 7 KB 网页链接
$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025189 Size: 7 KB 网页链接